drugset
drugset / Trial / NCT03972137

Heart Rate Variability Biofeedback for Smoking Cessation

NCT03972137 ↗

Phase 2 Completed 10 enrolled Rutgers, The State University of New Jersey National Institute on Drug Abuse (NIDA) · collab
NaSingle-groupOpen-labelTreatment

Summary

Open trial of heart rate variability biofeedback as an adjunct to individualized smoking cessation counseling (SCT) plus transdermal nicotine replacement patch (NRT) in smokers with elevated emotional distress.

Timeline

Start
2019-04-24
Primary completion
2020-02-20
Completion
2020-02-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Nicotine Unknown — Other

Indications

nicotine dependence